Sonoma Pharmaceuticals
SNOA
#11061
Rank
C$7.53 M
Marketcap
C$1.57
Share price
0.90%
Change (1 day)
-71.88%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2026 (TTM): -C$1.95 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are C$21.92 Million. In 2025 the company made an earning of -C$3.89 Million, an increase over its 2024 earnings that were of -C$6.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$1.95 Million-50%
2025 -C$3.89 Million-38.02%
2024 -C$6.27 Million0.54%
2023 -C$6.24 Million-31.5%
2022 -C$9.11 Million16.86%
2021 -C$7.79 Million194.32%
2020 -C$2.65 Million-58.76%
2019 -C$6.42 Million-65.66%
2018 -C$18.69 Million4.84%
2017 -C$17.83 Million-2.17%
2016 -C$18.23 Million32.12%
2015 -C$13.8 Million-307.74%
2014 C$6.63 M-197.5%
2013 -C$6.81 Million
2010 -C$10.64 Million-14.02%
2009 -C$12.38 Million-57.28%
2008 -C$28.97 Million-8.03%
2007 -C$31.5 Million3.85%
2006 -C$30.33 Million39.31%
2005 -C$21.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.12 Billion 5,577.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.51 Million 1,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA